Fidelity European Trust: 9.6% Share Price Return Amid Strong Continental Market Rally

Fidelity

Fidelity European Trust PLC (LON:FEV) monthly factsheet for February 2025.

Portfolio Manager Commentary 

Continental European equities continued their upward trajectory in February and have delivered strong returns on a year-to-date basis, outperforming US equity markets. Strong corporate earnings and optimism over a potential resolution to the Ukraine war contributed to the positive sentiment.   

The Trust underperformed the index during the month, primarily due to weak stock picking and overweight positioning in the industrials and financials sectors, while the impact of gearing was neutral. Following the positive reaction to results reported in January, the Trust’s holding in ASML came under pressure following reports that the US government is considering additional restrictions on semiconductor exports to China. The Trust’s exposure to private equity businesses Partners Group and EQT detracted as investors adjusted their expectations for US rate cuts following stronger-than-anticipated inflation data. Positively, Nestlé was the biggest contributor to the relative performance. Shares advanced after the company reported better than expected fiscal year 2024 results.   

Our focus is on finding attractively valued companies with good prospects for cash generation and dividend growth over the longer term. During the 12-month period ended in February 2025, the Trust recorded NAV and share price returns of 7.3% and 9.6% respectively, compared to the FTSE World Europe (ex UK) Index that returned 10.5%.  

Fidelity European Trust PLC (LON:FEV) aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Fidelity European Trust Factsheet – July volatility, Legrand and Bankinter gains

Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and Bankinter contributed positively. Over 12 months, the Trust’s NAV rose 1.8% and the share price 1.7%, compared with an 11.3% gain for the index.

European Investment Opportunities – Fidelity’s Quality Focus (LON:FEV)

FEV portfolio manager Marcel Stotzel highlights how quality companies with strong defensive characteristics can help investors navigate uncertainty and achieve long-term growth.

16.7% YTD return hails Fidelity European Trust’s strong credentials

Despite market headwinds, the Trust demonstrated resilience with standout contributions from Legrand and EQT and positive sector positioning. Over the past 12 months, NAV rose 2.3% and share price 5.5%, reflecting our focus on cash‑generative, dividend‑growing companies.

Fidelity European Trust May Factsheet – European equities moved higher

European equities rose in May amid volatility linked to US trade uncertainty. Fidelity European Trust underperformed the index, mainly due to weak positions in consumer sectors.

Fidelity European Trust proposes merger with HET to form £2.1bn trust

Fidelity European Trust PLC and Henderson European Trust have proposed a strategic merger aimed at enhancing market profile and reducing fees for shareholders.

3i Group and L’Oréal stock-picks boost Fidelity European Trust in April

Discover Fidelity European Trust PLC's April 2025 factsheet, highlighting market trends, portfolio performance, and strategic insights for European investments.

Search

Search